Is bariatric surgery an effective treatment for type II diabetic kidney disease?

Allon Friedman, Bruce Wolfe

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Type II diabetic kidney disease is devastating to patients and society alike. This review will evaluate bariatric surgery as a treatment for diabetic kidney disease primarily through its ability to induce and maintain regression of type II diabetes. The review begins by outlining the global challenge of diabetic kidney disease, its link to obesity, and the comparative benefits of bariatric surgery on weight and type II diabetes. It then surveys comprehensively the relevant literature, which reports that although bariatric surgery is associated with reductions in albuminuria, its effect on harder clinical end points like progression of diabetic kidney disease is not known. The review also includes a critical assessment of the risks and costs of bariatric surgery and concludes by acknowledging the major knowledge gaps in the field and providing research strategies to overcome them. Until these knowledge gaps are filled, clinicians will be forced to rely on their own subjective judgment in determining the benefit-risk ratio of bariatric surgery for patients with diabetic kidney disease.

Original languageEnglish (US)
Pages (from-to)528-535
Number of pages8
JournalClinical Journal of the American Society of Nephrology
Volume11
Issue number3
DOIs
StatePublished - Mar 7 2016

Fingerprint

Bariatric Surgery
Diabetic Nephropathies
Type 2 Diabetes Mellitus
Therapeutics
Aptitude
Albuminuria
Obesity
Odds Ratio
Weights and Measures
Costs and Cost Analysis
Research

ASJC Scopus subject areas

  • Nephrology
  • Transplantation
  • Epidemiology
  • Critical Care and Intensive Care Medicine

Cite this

Is bariatric surgery an effective treatment for type II diabetic kidney disease? / Friedman, Allon; Wolfe, Bruce.

In: Clinical Journal of the American Society of Nephrology, Vol. 11, No. 3, 07.03.2016, p. 528-535.

Research output: Contribution to journalArticle

@article{36c1cdd9e8764c3cab977fed233ef7db,
title = "Is bariatric surgery an effective treatment for type II diabetic kidney disease?",
abstract = "Type II diabetic kidney disease is devastating to patients and society alike. This review will evaluate bariatric surgery as a treatment for diabetic kidney disease primarily through its ability to induce and maintain regression of type II diabetes. The review begins by outlining the global challenge of diabetic kidney disease, its link to obesity, and the comparative benefits of bariatric surgery on weight and type II diabetes. It then surveys comprehensively the relevant literature, which reports that although bariatric surgery is associated with reductions in albuminuria, its effect on harder clinical end points like progression of diabetic kidney disease is not known. The review also includes a critical assessment of the risks and costs of bariatric surgery and concludes by acknowledging the major knowledge gaps in the field and providing research strategies to overcome them. Until these knowledge gaps are filled, clinicians will be forced to rely on their own subjective judgment in determining the benefit-risk ratio of bariatric surgery for patients with diabetic kidney disease.",
author = "Allon Friedman and Bruce Wolfe",
year = "2016",
month = "3",
day = "7",
doi = "10.2215/CJN.07670715",
language = "English (US)",
volume = "11",
pages = "528--535",
journal = "Clinical journal of the American Society of Nephrology : CJASN",
issn = "1555-9041",
publisher = "American Society of Nephrology",
number = "3",

}

TY - JOUR

T1 - Is bariatric surgery an effective treatment for type II diabetic kidney disease?

AU - Friedman, Allon

AU - Wolfe, Bruce

PY - 2016/3/7

Y1 - 2016/3/7

N2 - Type II diabetic kidney disease is devastating to patients and society alike. This review will evaluate bariatric surgery as a treatment for diabetic kidney disease primarily through its ability to induce and maintain regression of type II diabetes. The review begins by outlining the global challenge of diabetic kidney disease, its link to obesity, and the comparative benefits of bariatric surgery on weight and type II diabetes. It then surveys comprehensively the relevant literature, which reports that although bariatric surgery is associated with reductions in albuminuria, its effect on harder clinical end points like progression of diabetic kidney disease is not known. The review also includes a critical assessment of the risks and costs of bariatric surgery and concludes by acknowledging the major knowledge gaps in the field and providing research strategies to overcome them. Until these knowledge gaps are filled, clinicians will be forced to rely on their own subjective judgment in determining the benefit-risk ratio of bariatric surgery for patients with diabetic kidney disease.

AB - Type II diabetic kidney disease is devastating to patients and society alike. This review will evaluate bariatric surgery as a treatment for diabetic kidney disease primarily through its ability to induce and maintain regression of type II diabetes. The review begins by outlining the global challenge of diabetic kidney disease, its link to obesity, and the comparative benefits of bariatric surgery on weight and type II diabetes. It then surveys comprehensively the relevant literature, which reports that although bariatric surgery is associated with reductions in albuminuria, its effect on harder clinical end points like progression of diabetic kidney disease is not known. The review also includes a critical assessment of the risks and costs of bariatric surgery and concludes by acknowledging the major knowledge gaps in the field and providing research strategies to overcome them. Until these knowledge gaps are filled, clinicians will be forced to rely on their own subjective judgment in determining the benefit-risk ratio of bariatric surgery for patients with diabetic kidney disease.

UR - http://www.scopus.com/inward/record.url?scp=84960158149&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84960158149&partnerID=8YFLogxK

U2 - 10.2215/CJN.07670715

DO - 10.2215/CJN.07670715

M3 - Article

C2 - 26450931

AN - SCOPUS:84960158149

VL - 11

SP - 528

EP - 535

JO - Clinical journal of the American Society of Nephrology : CJASN

JF - Clinical journal of the American Society of Nephrology : CJASN

SN - 1555-9041

IS - 3

ER -